ask="7.60"
ask_size="200"
average_daily_volume="393410"
bid="6.35"
bid_size="300"
book_value="1.85"
change="N/A"
change_from_200_day_moving_average="-0.50"
change_from_50_day_moving_average="0.24"
change_from_52_week_high="-11.37"
change_From_52_week_low="1.40"
change_in_percent="N/A"
close="7.35"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.68"
ebitda="-116.64M"
eps_estimate_current_year="-1.62"
eps_estimate_next_quarter="-0.34"
eps_estimate_next_year="-1.43"
ex_dividend_date="N/A"
float_shares="40949000"
high="N/A"
high_52_weeks="18.72"
last_trade_date="2/13/2017"
last_trade_price="7.35"
last_trade_size="N/A"
last_trade_time="4:00pm"
low="N/A"
low_52_weeks="5.95"
market_capitalization="637.83M"
moving_average_200_day="7.85"
moving_average_50_day="7.11"
name="NovoCure Limited"
notes="N/A"
one_year_target_price="23.25"
open="N/A"
pe_ratio="N/A"
peg_ratio="-0.07"
percent_change_from_200_day_moving_average="-6.39%"
percent_change_from_50_day_moving_average="+3.37%"
percent_change_from_52_week_high="-60.74%"
percent_change_from_52_week_low="+23.53%"
previous_close="7.35"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.98"
price_per_sales="9.81"
revenue="65.03M"
shares_outstanding="86780000"
short_ratio="9.41"
stock_exchange="NMS"
symbol="NVCR"
volume="0"
weeks_range_52="5.95 - 18.72"
